AusPAR: Xeljanz
Australian Public Assessment Report
Device/Product Name
Xeljanz
Active ingredients
Tofacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04843-1-3
Submission Type
Extension of indications
Decision
Approved